Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2019
Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016-2017 and 2017-2018 Influenza Seasons in the United KingdomDavid Jackson, Max Pitcher, Chris Hudson, et al.
BMC Medicine|June 8, 2021
A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infantsChristine Elizabeth Jones, Anna Calvert, Jo Southern, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlersDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
Vaccine|October 28, 2020
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testingMarta Valente Pinto, Kimberly Davis, Nick Andrews, et al.
Vaccine|January 23, 2023
Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: A phase 4, multi-centre randomised trialNicholas C Grassly, Nick Andrews, Gillian Cooper, et al.
Frontiers in Public Health|March 6, 2023
Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS studyKarin Hansen, Elisabeth Rünow, Gustav Torisson, et al.
BMC Infectious Diseases|January 12, 2024
Retrospective database analysis for clinical diagnoses commonly associated with pneumococcal diseases in the Malaysian healthcare system over a 3-year period (2013-2015)Saravanan S R Sundaramurthy, Kristen E Allen, Mark A Fletcher, et al.
Microbiology Spectrum|July 11, 2024
Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UKDavid W Cleary, James Campling, Maria Lahuerta, et al.
The Lancet. Infectious Diseases|November 28, 2017
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trialDavid Goldblatt, Jo Southern, Nick J Andrews, et al.
The Pediatric Infectious Disease Journal|June 16, 2015
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool AgeDavid A Ishola, Nick Andrews, Pauline Waight, et al.
Pageof 7